Matthew M. Heeney

6.8k total citations
103 papers, 3.3k citations indexed

About

Matthew M. Heeney is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Matthew M. Heeney has authored 103 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 62 papers in Hematology and 31 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Matthew M. Heeney's work include Hemoglobinopathies and Related Disorders (74 papers), Iron Metabolism and Disorders (53 papers) and Blood groups and transfusion (15 papers). Matthew M. Heeney is often cited by papers focused on Hemoglobinopathies and Related Disorders (74 papers), Iron Metabolism and Disorders (53 papers) and Blood groups and transfusion (15 papers). Matthew M. Heeney collaborates with scholars based in United States, Canada and United Kingdom. Matthew M. Heeney's co-authors include Russell E. Ware, John J. Strouse, Karin E. Finberg, Nancy C. Andrews, Mark D. Fleming, Dean R. Campagna, Kyriacos Markianos, Mary Mayo, Howard A. Pearson and Kip R. Hartman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Matthew M. Heeney

98 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew M. Heeney United States 31 2.1k 1.8k 610 562 313 103 3.3k
Raffaella Origa Italy 25 2.9k 1.4× 2.6k 1.4× 739 1.2× 376 0.7× 350 1.1× 78 3.6k
Elizabeth A. Manci United States 20 1.8k 0.9× 1.3k 0.7× 580 1.0× 409 0.7× 93 0.3× 52 2.8k
Claudio Sandoval United States 25 559 0.3× 914 0.5× 320 0.5× 784 1.4× 209 0.7× 92 2.8k
Cage S. Johnson United States 29 2.0k 1.0× 1.5k 0.8× 527 0.9× 496 0.9× 41 0.1× 72 3.0k
Markus Metzler Germany 31 428 0.2× 787 0.4× 246 0.4× 718 1.3× 71 0.2× 130 2.8k
Sujit Sheth United States 21 884 0.4× 949 0.5× 227 0.4× 333 0.6× 148 0.5× 83 2.1k
Jaroslav Čermák Czechia 25 788 0.4× 2.1k 1.1× 98 0.2× 1.5k 2.7× 92 0.3× 192 3.7k
Carolyn Hoppe United States 29 1.9k 0.9× 1.7k 0.9× 587 1.0× 272 0.5× 32 0.1× 79 2.3k
Denis R. Miller United States 30 672 0.3× 985 0.5× 654 1.1× 412 0.7× 87 0.3× 98 2.7k
Tobias Wirenfeldt Klausen Denmark 32 436 0.2× 1.1k 0.6× 392 0.6× 665 1.2× 43 0.1× 143 3.3k

Countries citing papers authored by Matthew M. Heeney

Since Specialization
Citations

This map shows the geographic impact of Matthew M. Heeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Heeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Heeney more than expected).

Fields of papers citing papers by Matthew M. Heeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Heeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Heeney. The network helps show where Matthew M. Heeney may publish in the future.

Co-authorship network of co-authors of Matthew M. Heeney

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Heeney. A scholar is included among the top collaborators of Matthew M. Heeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Heeney. Matthew M. Heeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinney, Melissa A., Martha A. Clark, Linda T. Vo, et al.. (2025). A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs. Experimental Hematology. 152. 105264–105264.
2.
Ducamp, Sarah, Min Wu, Juan Putra, et al.. (2025). The GLYT1 inhibitor bitopertin mitigates erythroid PPIX production and liver disease in erythroid protoporphyria. Journal of Clinical Investigation. 135(18). 1 indexed citations
3.
4.
5.
Harris, Emily, Carolina Donado, Matthew M. Heeney, et al.. (2023). Ketamine use for management of vaso‐occlusive pain in pediatric sickle cell disease. Pediatric Blood & Cancer. 70(5). e30254–e30254. 2 indexed citations
6.
Donado, Carolina, Emily Harris, Matthew M. Heeney, et al.. (2023). Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study. Journal of Pain and Symptom Management. 65(5). e409–e415. 3 indexed citations
7.
Heeney, Matthew M., Miguel R. Abboud, Jessie Githanga, et al.. (2022). Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. Blood. 140(13). 1470–1481. 11 indexed citations
8.
Hulbert, Monica L., Deepa Manwani, Emily Riehm Meier, et al.. (2022). Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center. Pediatric Blood & Cancer. 70(1). e29961–e29961. 13 indexed citations
9.
Heeney, Matthew M., David C. Rees, Mariane de Montalembert, et al.. (2021). Initial Safety and Efficacy Results from the Phase II, Multicenter, Open-Label Solace-Kids Trial of Crizanlizumab in Adolescents with Sickle Cell Disease (SCD). Blood. 138(Supplement 1). 12–12. 7 indexed citations
10.
Daak, Ahmed, Carlton Dampier, Beng Fuh, et al.. (2018). Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial). Blood Advances. 2(15). 1969–1979. 31 indexed citations
11.
Esrick, Erica B., John Manis, Heather Daley, et al.. (2018). Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients. Blood Advances. 2(19). 2505–2512. 59 indexed citations
12.
Lesmana, Harry, Lisa Dyer, Xia Li, et al.. (2017). Alu element insertion inPKLRgene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients. Human Mutation. 39(3). 389–393. 5 indexed citations
13.
Frelinger, Andrew L., Joseph A. Jakubowski, Julie K. Brooks, et al.. (2012). Platelet Activation and Inhibition in Sickle Cell Disease (PAINS) Study. Blood. 120(21). 5147–5147. 3 indexed citations
14.
Vichinsky, Elliott, Françoise Bernaudin, Gian Luca Forni, et al.. (2011). Long‐term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease. British Journal of Haematology. 154(3). 387–397. 58 indexed citations
15.
Soranzo, Nicole, Serena Sanna, Eleanor Wheeler, et al.. (2010). Common Variants at 10 Genomic Loci Influence Hemoglobin A1C Levels via Glycemic and Nonglycemic Pathways. Diabetes. 59(12). 3229–3239. 291 indexed citations
16.
Finberg, Karin E., Matthew M. Heeney, Dean R. Campagna, et al.. (2008). Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nature Genetics. 40(5). 569–571. 484 indexed citations
17.
Luo, Hongyuan, Matthew M. Heeney, Winfred C. Wang, et al.. (2006). Hemoglobinopathies mimicking Hb S/β‐thalassemia: Hb S/S with α‐thalassemia and Hb S/Volga. American Journal of Hematology. 81(5). 361–365. 5 indexed citations
18.
Heeney, Matthew M., Matthew R. Whorton, Thad A. Howard, Chris A. Johnson, & Russell E. Ware. (2004). Chemical and Functional Analysis of Hydroxyurea Oral Solutions. Journal of Pediatric Hematology/Oncology. 26(3). 179–184. 39 indexed citations
19.
Heeney, Matthew M., Kathleen Delgrosso, Christine A. Johnson, et al.. (2002). Interpretation of Fetal Hemoglobin Only on Newborn Screening for Hemoglobinopathy. Journal of Pediatric Hematology/Oncology. 24(6). 499–502. 4 indexed citations
20.
Zhang, Xiaoli, Rho Hyun Seong, Mani Larijani, et al.. (1998). Distinct Stage-Specific cis-Active Transcriptional Mechanisms Control Expression of T Cell Coreceptor CD8α at Double- and Single-Positive Stages of Thymic Development. The Journal of Immunology. 161(5). 2254–2266. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raffaella Origa Breakdown of academic impact, for papers by Elizabeth A. Manci Breakdown of academic impact, for papers by Claudio Sandoval Breakdown of academic impact, for papers by Cage S. Johnson Breakdown of academic impact, for papers by Markus Metzler Breakdown of academic impact, for papers by Sujit Sheth Breakdown of academic impact, for papers by Jaroslav Čermák Breakdown of academic impact, for papers by Carolyn Hoppe Breakdown of academic impact, for papers by Denis R. Miller Breakdown of academic impact, for papers by Tobias Wirenfeldt Klausen
Rankless by CCL
2026